Across TCGA pan-cancer cohorts, RBISP1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RBISP1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RBISP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBISP1 is over-expressed in tumor, although a few such as STAD and THCA show the opposite, repressed pattern.

LIHC, STAD, and THCA are the cancer types where RBISP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBISP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.055	.003	4	view →
STAD	Male	III,IV	−0.173	.001	3	view →
THCA	All	All	−0.041	.009	2	view →
LUAD	Female	All	−0.110	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RBISP1 RNA expression & survival · all RBISP1 data types